X
RMD icon

Xponance’s ResMed RMD Stock Holding History

Xponance’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.61M Buy
29,429
+3,329
+13% +$830K 0.05% 294
2025
Q4 		$6.29M Buy
26,100
+1,409
+6% +$360K 0.05% 287
2025
Q3 		$6.76M Sell
24,691
-830
-3% -$227K 0.05% 267
2025
Q2 		$6.58M Sell
25,521
-3,540
-12% -$844K 0.06% 267
2025
Q1 		$6.51M Buy
29,061
+353
+1% +$82.4K 0.06% 245
2024
Q4 		$6.57M Sell
28,708
-2,564
-8% -$617K 0.06% 247
2024
Q3 		$7.63M Sell
31,272
-3,182
-9% -$711K 0.07% 216
2024
Q2 		$6.6M Sell
34,454
-12,552
-27% -$2.55M 0.07% 226
2024
Q1 		$9.31M Buy
47,006
+268
+0.6% +$49.1K 0.1% 177
2023
Q4 		$8.04M Buy
46,738
+3,363
+8% +$517K 0.1% 177
2023
Q3 		$6.41M Buy
43,375
+6,359
+17% +$1.15M 0.09% 193
2023
Q2 		$8.09M Buy
37,016
+4,478
+14% +$998K 0.11% 164
2023
Q1 		$7.13M Buy
32,538
+671
+2% +$146K 0.1% 180
2022
Q4 		$6.63M Buy
31,867
+3,121
+11% +$686K 0.11% 182
2022
Q3 		$6.28M Buy
28,746
+2,217
+8% +$505K 0.12% 151
2022
Q2 		$5.56M Buy
26,529
+3,638
+16% +$774K 0.11% 159
2022
Q1 		$5.55M Buy
22,891
+316
+1% +$76.4K 0.09% 181
2021
Q4 		$5.88M Buy
22,575
+1,990
+10% +$516K 0.09% 188
2021
Q3 		$5.42M Sell
20,585
-659
-3% -$180K 0.1% 173
2021
Q2 		$5.24M Buy
21,244
+91
+0.4% +$19.1K 0.1% 168
2021
Q1 		$4.1M Buy
21,153
+47
+0.2% +$9.43K 0.09% 194
2020
Q4 		$4.49M Buy
21,106
+356
+2% +$71K 0.1% 174
2020
Q3 		$3.56M Buy
20,750
+18
+0.1% +$3.32K 0.09% 189
2020
Q2 		$3.98M Buy
+20,732
New +$3.39M 0.1% 174

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Xponance's RMD Position: Q1 2026 in Review

Xponance increased its ResMed (RMD) stake by 13% in Q1 2026, buying an estimated $830K and bringing the position to 29,429 shares worth $6.61M. The position accounts for 0.05% of the portfolio, ranked #294.

Xponance first reported a position in RMD in Q2 2020 and has held it in 24 quarters since. The position peaked at $9.31M in Q1 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Xponance held 29,429 shares of ResMed worth $6.61M as of Q1 2026.
  • Xponance bought 3,329 ResMed shares in Q1 2026, an estimated $830K.
  • ResMed made up 0.05% of Xponance's portfolio in Q1 2026, its #294 holding.
  • Xponance first reported a position in ResMed in Q2 2020 and has held it in 24 quarters since.
  • Xponance's ResMed position peaked at $9.31M in Q1 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.